Although they did not identify CXCR4 as a potential target, Rubin et al., had previously shown that CXCR4 antagonism inhibited glioblastoma multiforme growth, suggesting that CXCR4 was an appropriate target for glioblastoma therapy [29]. Here, CXCR4 is linked to glioblastoma.